ConductScience.org, home

Paper32077599

New epidemiology of hepatitis delta.

Vlachogiannakos J and 1 other. Liver Int, 2020. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. New epidemiology of hepatitis delta. Papers, record 32077599. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32077599

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New epidemiology of hepatitis delta.
PubMed
Journal
Liver Int
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
2.36
iCite
Revised in PubMed
2021-06-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vlachogiannakos JJiannis
2Papatheodoridis GVGeorge Vhttps://orcid.org/0000-0002-3518-4060

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
CoinfectionMajor topic
Hepatitis BMajor topic
Hepatitis DMajor topic
Liver NeoplasmsMajor topic
Europe
Hepatitis B virus
Hepatitis Delta Virus
Humans
Prevalence

Source PubMed

Download CSV of topics

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
42357642Serological and Molecular Epidemiology of Hepatitis B, C, and D Viruses in Northwest Russia: A Population-Based Cross-Sectional Study.Viruses2026https://conductscience.org/library/papers/42357642PubMed
41754517Suboptimal Linkage to Care of Delta-Infected Patients in an Area with Increasing Migration-Driven Prevalence of Hepatitis D in Recent Years.Viruses2026https://conductscience.org/library/papers/41754517PubMed
41746099Towards HDV Elimination Through HBV Vaccination: Global Strategies, Challenges, and Policy Gaps.Vaccines (Basel)2026https://conductscience.org/library/papers/41746099PubMed
41408032Hepatitis A to E in People with HIV: A Virus-Specific Review of Prevention and Treatment.Infect Dis Ther2026https://conductscience.org/library/papers/41408032PubMed
41031102Regional Mortality From Chronic Liver Diseases in African Countries Attributable to Hepatitis B Virus and Hepatitis C Virus Infections From 1990 to 2021 and Projections to 2030.Open Forum Infect Dis2025https://conductscience.org/library/papers/41031102PubMed
40881490Hepatitis B virus and hepatitis D virus co-infection complicated by autoimmune hepatitis: Two case reports.World J Clin Cases2025https://conductscience.org/library/papers/40881490PubMed
40613912Proteins and peptides as antigen candidates for the immunodiagnosis of hepatitis D.Amino Acids2025https://conductscience.org/library/papers/40613912PubMed
40214253A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D.J Clin Microbiol2025https://conductscience.org/library/papers/40214253PubMed
39980422Low coverage of hepatitis D virus testing in individuals with hepatitis B virus and HIV, the Netherlands, 2000 to 2022.Euro Surveill2025https://conductscience.org/library/papers/39980422PubMed
39599805Genetic Spatio-Temporal Analysis of Hepatitis D Virus Infection in Western Brazilian Amazon.Viruses2024https://conductscience.org/library/papers/39599805PubMed
38689751Prospective study of hepatitis B and D epidemiology and risk factors in Romania: A 10-year update.World J Hepatol2024https://conductscience.org/library/papers/38689751PubMed
38390020[Delta hepatitis in Africa: epidemiological and clinical particularities].Med Trop Sante Int2023https://conductscience.org/library/papers/38390020PubMed
37632029Cellular Factors Involved in the Hepatitis D Virus Life Cycle.Viruses2023https://conductscience.org/library/papers/37632029PubMed
37512809Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers.Microorganisms2023https://conductscience.org/library/papers/37512809PubMed
37408247HDV RNA Levels and Progression of Hepatitis Delta Infection: A 14 Year Follow Up Experience in Italy.Cells2023https://conductscience.org/library/papers/37408247PubMed
36908749Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment.JHEP Rep2023https://conductscience.org/library/papers/36908749PubMed
36727249[Sero-epidemiological characteristics of the hepatitis D virus infection among hepatitis B virus infected-patients at a single center in Xinjiang region].Zhonghua Gan Zang Bing Za Zhi2022https://conductscience.org/library/papers/36727249PubMed
36621853Diagnosis of HDV: From virology to non-invasive markers of fibrosis.Liver Int2023https://conductscience.org/library/papers/36621853PubMed
34717740Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis.Gut Pathog2021https://conductscience.org/library/papers/34717740PubMed
34694876Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological Study.Antimicrob Agents Chemother2022https://conductscience.org/library/papers/34694876PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32077599

GET https://conductscience.org/api/papers/v1/32077599/cited_by?page=2